| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10966635 | Vaccine | 2014 | 6 Pages |
Abstract
The authors attempted to summarise and tackle key gaps in the existing evidence concerning quality and efficacy of influenza vaccines, aiming at favouring a common understanding and a coordinated approach across stakeholders.
Keywords
TIVHaemagglutination inhibition assayHighly pathogenic avian influenza virusesSRIDLAIVHPAIVRCTsSRHCMIRT-PCRCOPhaemagglutininLC–MS/MSRandomised clinical trialsSDS-PAGESodium dodecyl sulfate polyacrylamide gel electrophoresisELISAEnzyme-linked immunosorbent assaySurface plasmon resonanceSPRStakeholdersCorrelate of protectionneuraminidaseNucleoproteinlive attenuated influenza vaccineInfluenza vaccinationreverse transcription-polymerase chain reactionpandemicmatrix protein 2Vaccine efficacyliquid chromatography–tandem mass spectrometryHPLChigh-performance liquid chromatography
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Michael Pfleiderer, Jean-Hugues Trouvin, Daniel Brasseur, Marta Gränstrom, Ragini Shivji, Manuela Mura, Marco Cavaleri,